Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 46.57B | 62.40B | 60.44B | 65.81B | 62.80B | 58.32B |
Gross Profit | 34.25B | 46.11B | 44.84B | 44.44B | 43.10B | 41.97B |
EBITDA | 12.50B | 16.62B | 18.41B | 20.80B | 22.19B | 22.97B |
Net Income | 5.72B | 8.28B | 11.50B | 12.42B | 13.93B | 14.29B |
Balance Sheet | ||||||
Total Assets | 94.77B | 101.80B | 90.47B | 88.15B | 92.32B | 86.14B |
Cash, Cash Equivalents and Short-Term Investments | 12.03B | 17.32B | 10.51B | 9.77B | 13.03B | 12.33B |
Total Debt | 33.03B | 36.35B | 30.78B | 26.54B | 32.55B | 15.41B |
Total Liabilities | 61.72B | 65.64B | 57.20B | 56.14B | 63.97B | 46.37B |
Stockholders Equity | 28.68B | 31.77B | 29.32B | 27.99B | 24.49B | 36.34B |
Cash Flow | ||||||
Free Cash Flow | 12.59B | 15.09B | 11.45B | 13.34B | 16.02B | 11.47B |
Operating Cash Flow | 15.23B | 20.09B | 16.09B | 17.89B | 20.57B | 18.16B |
Investing Cash Flow | -7.74B | -11.39B | -10.64B | -3.57B | -6.55B | -9.08B |
Financing Cash Flow | -4.81B | -6.82B | -4.24B | -15.72B | -12.70B | -9.24B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $248.84B | 18.84 | 32.82% | 3.02% | 12.38% | -12.67% | |
77 Outperform | $266.11B | 31.78 | 19.76% | 1.83% | 15.08% | 29.15% | |
76 Outperform | $223.58B | 13.80 | 35.44% | 3.63% | 2.00% | 20.01% | |
75 Outperform | $286.51B | 26.09 | 31.98% | 3.01% | 7.26% | -8.64% | |
75 Outperform | $124.25B | 12.66 | 8.39% | 4.35% | -9.32% | 120.62% | |
68 Neutral | $137.18B | 21.99 | 33.26% | 2.79% | 3.69% | 501.26% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |